Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Antimicrob Agents Chemother ; 58(12): 7560-4, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25267665

ABSTRACT

The efficacy of oral tigecycline treatment (2 mg/kg of body weight for 7 days) of Clostridium difficile infection (CDI) was evaluated in the gnotobiotic pig model, and its effect on human gut microflora transplanted into the gnotobiotic pig was determined. Tigecycline oral treatment improved survival, clinical signs, and lesion severity and markedly decreased concentrations of Firmicutes but did not promote CDI. Our data showed that oral tigecycline treatment has a potential beneficial effect on the treatment of CDI.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridioides difficile/drug effects , Enterocolitis, Pseudomembranous/drug therapy , Germ-Free Life , Microbiota/drug effects , Minocycline/analogs & derivatives , Administration, Oral , Animals , Clostridioides difficile/growth & development , Drug Administration Schedule , Enterocolitis, Pseudomembranous/microbiology , Enterocolitis, Pseudomembranous/pathology , Fluoroquinolones/pharmacology , Humans , Interleukin-8/antagonists & inhibitors , Interleukin-8/biosynthesis , Interleukin-8/metabolism , Minocycline/pharmacology , Pyrimidinones/pharmacology , Swine , Tigecycline , Vancomycin/pharmacology
2.
PLoS One ; 9(10): e111075, 2014.
Article in English | MEDLINE | ID: mdl-25347821

ABSTRACT

The use of anti-toxin human monoclonal antibodies (HMab) as treatment for C. difficile infection has been investigated in animal models and human clinical trials as an alternative to or in combination with traditional antibiotic therapy. While HMab therapy appears to be a promising option, how systemically administered IgG antibodies protect the colonic mucosa during Clostridium difficile infection is unknown. Using the gnotobiotic piglet model of Clostridium difficile infection, we administered a mixture of anti-TcdA and anti-TcdB HMabs systemically to piglets infected with either pathogenic or non-pathogenic C. difficile strains. The HMabs were present throughout the small and large intestinal tissue of both groups, but significant HMabs were present in the lumen of the large intestines only in the pathogenic strain-infected group. Similarly, HMabs measured in the large intestine over a period of 2-4 days following antibody administration were not significantly different over time in the gut mucosa among the groups, but concentrations in the lumen of the large intestine were again consistently higher in the pathogenic strain-infected group. These results indicate that systemically administered HMab IgG reaches the gut mucosa during the course of CDI, protecting the host against systemic intoxication, and that leakage through the damaged colon likely protects the mucosa from further damage, allowing initiation of repair and recovery.


Subject(s)
Antitoxins/administration & dosage , Clostridioides difficile/immunology , Colon/pathology , Enterocolitis, Pseudomembranous/pathology , Enterocolitis, Pseudomembranous/prevention & control , Immunoglobulin G/administration & dosage , Intestinal Mucosa/pathology , Animals , Antibodies, Monoclonal/administration & dosage , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/immunology , Bacterial Toxins/antagonists & inhibitors , Bacterial Toxins/immunology , Colon/immunology , Disease Models, Animal , Enterocolitis, Pseudomembranous/mortality , Enterotoxins/antagonists & inhibitors , Enterotoxins/immunology , Humans , Intestinal Mucosa/immunology , Swine
3.
PLoS One ; 8(6): e66462, 2013.
Article in English | MEDLINE | ID: mdl-23840478

ABSTRACT

BACKGROUND: Shiga toxin (Stx)-producing Escherichia coli cause severe intestinal infections involving colonization of epithelial Peyer's patches and formation of attachment/effacement (A/E) lesions. These lesions trigger leukocyte infiltration followed by inflammation and intestinal hemorrhage. Systems biology, which explores the crosstalk of Stx-producing Escherichia coli with the in vivo host environment, may elucidate novel molecular pathogenesis aspects. METHODOLOGY/PRINCIPAL FINDINGS: Enterohemorrhagic E. coli strain 86-24 produces Shiga toxin-2 and belongs to the serotype O157:H7. Bacterial cells were scrapped from stationary phase cultures (the in vitro condition) and used to infect gnotobiotic piglets via intestinal lavage. Bacterial cells isolated from the piglets' guts constituted the in vivo condition. Cell lysates were subjected to quantitative 2D gel and shotgun proteomic analyses, revealing metabolic shifts towards anaerobic energy generation, changes in carbon utilization, phosphate and ammonia starvation, and high activity of a glutamate decarboxylase acid resistance system in vivo. Increased abundance of pyridine nucleotide transhydrogenase (PntA and PntB) suggested in vivo shortage of intracellular NADPH. Abundance changes of proteins implicated in lipopolysaccharide biosynthesis (LpxC, ArnA, the predicted acyltransferase L7029) and outer membrane (OM) assembly (LptD, MlaA, MlaC) suggested bacterial cell surface modulation in response to activated host defenses. Indeed, there was evidence for interactions of innate immunity-associated proteins secreted into the intestines (GP340, REG3-γ, resistin, lithostathine, and trefoil factor 3) with the bacterial cell envelope. SIGNIFICANCE: Proteomic analysis afforded insights into system-wide adaptations of strain 86-24 to a hostile intestinal milieu, including responses to limited nutrients and cofactor supplies, intracellular acidification, and reactive nitrogen and oxygen species-mediated stress. Protein and lipopolysaccharide compositions of the OM were altered. Enhanced expression of type III secretion system effectors correlated with a metabolic shift back to a more aerobic milieu in vivo. Apparent pathogen pattern recognition molecules from piglet intestinal secretions adhered strongly to the bacterial cell surface.


Subject(s)
Escherichia coli Proteins/biosynthesis , Intestines/microbiology , Proteomics , Shiga Toxin/biosynthesis , Shiga-Toxigenic Escherichia coli/metabolism , Animals , Chromatography, Liquid , Electrophoresis, Gel, Two-Dimensional , Germ-Free Life , Homeostasis , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Swine , Tandem Mass Spectrometry
4.
Antimicrob Agents Chemother ; 57(8): 4039-41, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23689716

ABSTRACT

The novel antibiotic MBX-500, dosed at 100, 200, or 400 mg/kg twice daily for 7 days, was evaluated for the treatment of Clostridium difficile infection (CDI) in the gnotobiotic pig model. MBX-500 increased survival at all doses and at high doses improved clinical signs and reduced lesion severity, similar to vancomycin. Our results show that MBX-500 is an effective antibiotic for the treatment of diarrhea associated with CDI and prevents severe systemic disease.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridioides difficile/pathogenicity , Clostridium Infections/drug therapy , Diarrhea/drug therapy , Fluoroquinolones/pharmacology , Pyrimidinones/pharmacology , Animals , Colon/microbiology , Colon/pathology , Diarrhea/microbiology , Disease Models, Animal , Drug Evaluation, Preclinical , Germ-Free Life , Kaplan-Meier Estimate , Severity of Illness Index , Swine , Treatment Outcome , Vancomycin/pharmacology
5.
Gut Microbes ; 4(3): 193-200, 2013.
Article in English | MEDLINE | ID: mdl-23549377

ABSTRACT

Easy access to next generation sequencing has enabled the rapid analysis of complex microbial populations. To take full advantage of these technologies, animal models enabling the manipulation of human microbiomes and the study of the impact of such perturbations on the host are needed. To this aim we are developing experimentally tractable and clinically relevant pig models of the human adult and infant gastro-intestinal tract. The intestine of germ-free piglets was populated with human adult or infant fecal microbial populations, and the piglets were maintained on solid or milk diet, respectively. Amplicons of 16S rRNA V6 region were deep-sequenced to monitor to what extent the transplanted human microbiomes changed in the pig. Within 24 h of transfer of human fecal microbiome to pigs, bacterial microbiomes rich in Proteobacteria emerged. These populations evolved toward a more diverse composition rich in Bacteroidetes and Firmicutes. In the experiment where infant microbiome was used, the phylogenetic composition of the transplanted bacterial population converged toward that of the human inoculum. A majority of sequences belonged to a relatively small number of operational taxonomic units, whereas at the other end of the abundance spectrum, a large number of rare and transient OTUs were detected. Analysis of fecal and colonic microbiomes originating from the same animal indicate that feces closely replicate the colonic microbiome. We conclude that the pig intestine can be colonized with human fecal microbiomes to generate a realistic model of the human GI tract.


Subject(s)
Gastrointestinal Tract/microbiology , Metagenome , Models, Animal , Aged , Animals , Biota , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Female , Germ-Free Life , High-Throughput Nucleotide Sequencing , Humans , Infant , Male , Middle Aged , RNA, Ribosomal, 16S/genetics , Swine , Time Factors
6.
PLoS One ; 6(11): e26554, 2011.
Article in English | MEDLINE | ID: mdl-22087229

ABSTRACT

BACKGROUND: The recent outbreak of severe infections with Shiga toxin (Stx) producing Escherichia coli (STEC) serotype O104:H4 highlights the need to understand horizontal gene transfer among E. coli strains, identify novel virulence factors and elucidate their pathogenesis. Quantitative shotgun proteomics can contribute to such objectives, allowing insights into the part of the genome translated into proteins and the connectivity of biochemical pathways and higher order assemblies of proteins at the subcellular level. METHODOLOGY/PRINCIPAL FINDINGS: We examined protein profiles in cell lysate fractions of STEC strain 86-24 (serotype O157:H7), following growth in cell culture or bacterial isolation from intestines of infected piglets, in the context of functionally and structurally characterized biochemical pathways of E. coli. Protein solubilization in the presence of Triton X-100, EDTA and high salt was followed by size exclusion chromatography into the approximate M(r) ranges greater than 280 kDa, 280-80 kDa and 80-10 kDa. Peptide mixtures resulting from these and the insoluble fraction were analyzed by quantitative 2D-LC-nESI-MS/MS. Of the 2521 proteins identified at a 1% false discovery rate, representing 47% of all predicted E. coli O157:H7 gene products, the majority of integral membrane proteins were enriched in the high M(r) fraction. Hundreds of proteins were enriched in a M(r) range higher than that predicted for a monomer supporting their participation in protein complexes. The insoluble STEC fraction revealed enrichment of aggregation-prone proteins, including many that are part of large structure/function entities such as the ribosome, cytoskeleton and O-antigen biosynthesis cluster. SIGNIFICANCE: Nearly all E. coli O157:H7 proteins encoded by prophage regions were expressed at low abundance levels or not detected. Comparative quantitative analyses of proteins from distinct cell lysate fractions allowed us to associate uncharacterized proteins with membrane attachment, potential participation in stable protein complexes, and susceptibility to aggregation as part of larger structural assemblies.


Subject(s)
Escherichia coli O157/chemistry , Escherichia coli Proteins/analysis , Proteome/analysis , Proteomics/methods , Animals , Intestines/microbiology , Membrane Proteins , Multiprotein Complexes/analysis , Swine
7.
BMC Microbiol ; 11: 147, 2011 Jun 24.
Article in English | MEDLINE | ID: mdl-21702961

ABSTRACT

BACKGROUND: Shigella dysenteriae serotype 1 (SD1) causes the most severe form of epidemic bacillary dysentery. Quantitative proteome profiling of Shigella dysenteriae serotype 1 (SD1) in vitro (derived from LB cell cultures) and in vivo (derived from gnotobiotic piglets) was performed by 2D-LC-MS/MS and APEX, a label-free computationally modified spectral counting methodology. RESULTS: Overall, 1761 proteins were quantitated at a 5% FDR (false discovery rate), including 1480 and 1505 from in vitro and in vivo samples, respectively. Identification of 350 cytoplasmic membrane and outer membrane (OM) proteins (38% of in silico predicted SD1 membrane proteome) contributed to the most extensive survey of the Shigella membrane proteome reported so far. Differential protein abundance analysis using statistical tests revealed that SD1 cells switched to an anaerobic energy metabolism under in vivo conditions, resulting in an increase in fermentative, propanoate, butanoate and nitrate metabolism. Abundance increases of transcription activators FNR and Nar supported the notion of a switch from aerobic to anaerobic respiration in the host gut environment. High in vivo abundances of proteins involved in acid resistance (GadB, AdiA) and mixed acid fermentation (PflA/PflB) indicated bacterial survival responses to acid stress, while increased abundance of oxidative stress proteins (YfiD/YfiF/SodB) implied that defense mechanisms against oxygen radicals were mobilized. Proteins involved in peptidoglycan turnover (MurB) were increased, while ß-barrel OM proteins (OmpA), OM lipoproteins (NlpD), chaperones involved in OM protein folding pathways (YraP, NlpB) and lipopolysaccharide biosynthesis (Imp) were decreased, suggesting unexpected modulations of the outer membrane/peptidoglycan layers in vivo. Several virulence proteins of the Mxi-Spa type III secretion system and invasion plasmid antigens (Ipa proteins) required for invasion of colonic epithelial cells, and release of bacteria into the host cell cytosol were increased in vivo. CONCLUSIONS: Global proteomic profiling of SD1 comparing in vivo vs. in vitro proteomes revealed differential expression of proteins geared towards survival of the pathogen in the host gut environment, including increased abundance of proteins involved in anaerobic energy respiration, acid resistance and virulence. The immunogenic OspC2, OspC3 and IpgA virulence proteins were detected solely under in vivo conditions, lending credence to their candidacy as potential vaccine targets.


Subject(s)
Bacterial Proteins/biosynthesis , Gene Expression Regulation, Bacterial , Metabolic Networks and Pathways , Proteome/analysis , Shigella dysenteriae/chemistry , Shigella dysenteriae/physiology , Virulence Factors/biosynthesis , Animals , Electrophoresis, Gel, Two-Dimensional , Energy Metabolism , Mass Spectrometry , Shigella dysenteriae/growth & development , Shigella dysenteriae/pathogenicity , Swine , Virulence
8.
J Infect Dis ; 201(6): 903-11, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20136414

ABSTRACT

BACKGROUND: The lack of a standardized laboratory animal model that mimics key aspects of human shigellosis remains a major obstacle to addressing questions about pathogenesis, screening therapeutics, and evaluation of vaccines. METHODS: We characterized a piglet model for Shigella dysenteriae type 1. RESULTS: Piglets developed acute diarrhea, anorexia, and dehydration, which could often be fatal, with symptom severity depending on age and dose. Bacteria were apparent in the lumen and on the surface epithelium throughout the gut initially, but severe mucosal damage and bacterial cellular invasion were most profound in the colon. Detached necrotic colonocytes were present in the lumen, with inflammatory cells outpouring from damaged mucosa. High levels of interleukin (IL)-8 and IL-12 were followed by high levels of other proinflammatory cytokines. Elevated levels of tumor necrosis factor-alpha, IL-1beta, IL-6, and IL-10 were detected in feces and in gut segments from infected animals. Bacteria were present inside epithelial cells and within colonic lamina propria. In contrast, an isogenic strain lacking Shiga toxin induced similar but milder symptoms, with moderate mucosal damage and lower cytokine levels. CONCLUSION: We conclude that piglets are highly susceptible to shigellosis, providing a useful tool with which to compare vaccine candidates for immunogenicity, reactogenicity, and response to challenge; investigate the role of virulence factors; and test the efficacy of microbial agents.


Subject(s)
Disease Models, Animal , Dysentery, Bacillary/physiopathology , Gastroenteritis/microbiology , Shigella dysenteriae , Swine , Animals , Case-Control Studies , Colony Count, Microbial , Cytokines/analysis , Dysentery, Bacillary/microbiology , Euthanasia, Animal , Feces/microbiology , Gastroenteritis/physiopathology , Gastrointestinal Tract/microbiology , Interleukin-12 , Interleukin-8 , Microscopy, Electron , Shigella dysenteriae/immunology
9.
Proteomics ; 9(22): 5029-45, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19813213

ABSTRACT

Shigella dysenteriae serotype 1 (SD1) causes the most severe form of epidemic bacillary dysentery. We present the first comprehensive proteome analysis of this pathogen, profiling proteins from bacteria cultured in vitro and bacterial isolates from the large bowel of infected gnotobiotic piglets (in vivo). Overall, 1061 distinct gene products were identified. Differential display analysis revealed that SD1 cells switched to an anaerobic energy metabolism in vivo. High in vivo abundances of amino acid decarboxylases (GadB and AdiA) which enhance pH homeostasis in the cytoplasm and protein disaggregation chaperones (HdeA, HdeB and ClpB) were indicative of a coordinated bacterial survival response to acid stress. Several type III secretion system effectors were increased in abundance in vivo, including OspF, IpaC and IpaD. These proteins are implicated in invasion of colonocytes and subversion of the host immune response in S. flexneri. These observations likely reflect an adaptive response of SD1 to the hostile host environment. Seven proteins, among them the type III secretion system effectors OspC2 and IpaB, were detected as antigens in Western blots using piglet antisera. The outer membrane protein OmpA, the heat shock protein HtpG and OspC2 represent novel SD1 subunit vaccine candidates and drug targets.


Subject(s)
Bacterial Proteins/metabolism , Dysentery, Bacillary/microbiology , Gene Expression Regulation, Bacterial , Proteome , Shigella dysenteriae/metabolism , Virulence Factors/analysis , Animals , Bacterial Proteins/analysis , Computational Biology , Electrophoresis, Gel, Two-Dimensional , Intestine, Large/microbiology , Mass Spectrometry , Shigella dysenteriae/pathogenicity , Swine , Virulence Factors/metabolism
10.
Proteome Sci ; 7: 22, 2009 Jun 29.
Article in English | MEDLINE | ID: mdl-19563668

ABSTRACT

The in vitro stationary phase proteome of the human pathogen Shigella dysenteriae serotype 1 (SD1) was quantitatively analyzed in Coomassie Blue G250 (CBB)-stained 2D gels. More than four hundred and fifty proteins, of which 271 were associated with distinct gel spots, were identified. In parallel, we employed 2D-LC-MS/MS followed by the label-free computationally modified spectral counting method APEX for absolute protein expression measurements. Of the 4502 genome-predicted SD1 proteins, 1148 proteins were identified with a false positive discovery rate of 5% and quantitated using 2D-LC-MS/MS and APEX. The dynamic range of the APEX method was approximately one order of magnitude higher than that of CBB-stained spot intensity quantitation. A squared Pearson correlation analysis revealed a reasonably good correlation (R2 = 0.67) for protein quantities surveyed by both methods. The correlation was decreased for protein subsets with specific physicochemical properties, such as low Mr values and high hydropathy scores. Stoichiometric ratios of subunits of protein complexes characterized in E. coli were compared with APEX quantitative ratios of orthologous SD1 protein complexes. A high correlation was observed for subunits of soluble cellular protein complexes in several cases, demonstrating versatile applications of the APEX method in quantitative proteomics.

11.
Infect Immun ; 77(6): 2294-303, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19307220

ABSTRACT

Toxin A (TcdA) and toxin B (TcdB) are major virulence factors of Clostridium difficile. These two toxins intoxicate cultured cells by similar mechanisms, and TcdB generally is more potent than TcdA in cultured cells. The exact reason for this difference is unclear. Here, we report that the cellular effects of TcdA can be substantially enhanced via an opsonizing antibody through Fc gamma receptor I (FcgammaRI)-mediated endocytosis. A TcdA-specific monoclonal antibody, A1H3, was found to significantly enhance the cytotoxicity of TcdA to macrophages and monocytes. The A1H3-dependent enhancement of glucosyltransferase activity, cytoskeleton disruption, and tumor necrosis factor alpha production induced by TcdA was further demonstrated using RAW 264.7 cells. Subsequent experiments indicated that the interaction of FcgammaRI with A1H3 underlays the antibody-dependent enhancement of the cellular effects of TcdA. While blocking FcgammaRII and FcgammaRIII with anti-CD16/32 antibodies did not affect the TcdA-mediated glucosylation of Rac1 in RAW 264.7 cells, presaturation of FcgammaRI with anti-CD64 antibodies in THP1 cells significantly reduced this activity. Incubation of a TcdA-A1H3 immune complex with recombinant mouse CD64 completely abrogated the A1H3-mediated enhancement of the glucosyltransferase activity of TcdA in RAW 264.7 cells. Moreover, expression of FcgammaRI in CHO cells strikingly enhanced the sensitivity of these cells to TcdA complexed with A1H3. We showed that the presence of A1H3 facilitated cell surface recruitment of TcdA, contributing to the antibody-dependent, FcgammaRI-mediated enhancement of TcdA activity. Finally, studies using chlorpromazine and endosomal acidification inhibitors revealed an important role of the endocytic pathway in the A1H3-dependent enhancement of TcdA activity.


Subject(s)
Antibodies, Bacterial/immunology , Bacterial Toxins/immunology , Bacterial Toxins/metabolism , Clostridioides difficile/immunology , Endocytosis , Enterotoxins/immunology , Enterotoxins/metabolism , Receptors, IgG/immunology , Receptors, IgG/metabolism , Animals , Antibodies, Monoclonal/immunology , Cell Line , Glycosylation , Humans , Macrophages/immunology , Mice , Neuropeptides/metabolism , rac GTP-Binding Proteins/metabolism , rac1 GTP-Binding Protein
12.
J Infect Dis ; 199(4): 486-93, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19125676

ABSTRACT

BACKGROUND: Shiga toxin (Stx)-producing Escherichia coli (STEC), especially O157:H7, cause bloody diarrhea, and in 3%-15% of individuals the infection leads to hemolytic uremic syndrome (HUS) or other complications. Use of antibiotics to treat STEC infections is controversial. Here, we describe the use of piglets to evaluate the efficacy and mechanism of action of antibiotics in these infections. METHODS: The effects of 2 antibiotics on STEC toxin production and their mechanisms of action were first determined by enzyme-linked immunosorbent assay and subsequently evaluated clinically in the gnotobiotic piglet infection model. RESULTS: In vitro treatment of clinical and isogenic strains with ciprofloxacin increased the production of Stx2 via phage induction but not the production of Stx1. Azithromycin caused no significant increase in toxin production. After treatment with ciprofloxacin, infected piglets had diarrhea and the severe fatal neurological symptoms associated with Stx2 intoxication. Characteristic petechial hemorrhages in the cerebellum were more severe in ciprofloxacin-treated animals than in control animals. In contrast, azithromycin-treated piglets survived the infection and had little or no brain hemorrhaging. CONCLUSIONS: The increased in vitro toxin production caused by ciprofloxacin was strongly correlated with death and an increased rate of cerebellar hemorrhage, in contrast to the effect of azithromycin. The piglet is a suitable model for determining the effectiveness and safety of antibiotics available to treat patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Ciprofloxacin/therapeutic use , Escherichia coli Infections/drug therapy , Escherichia coli O157/drug effects , Germ-Free Life , Analysis of Variance , Animals , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/pharmacology , Azithromycin/adverse effects , Azithromycin/pharmacology , Cerebellum/pathology , Chi-Square Distribution , Ciprofloxacin/adverse effects , Ciprofloxacin/pharmacology , Disease Models, Animal , Drug Evaluation, Preclinical , Escherichia coli Infections/microbiology , Escherichia coli Infections/pathology , Escherichia coli O157/genetics , Escherichia coli O157/metabolism , Mutation , Rec A Recombinases/genetics , Shiga Toxin 1/metabolism , Shiga Toxin 2/analysis , Shiga Toxin 2/metabolism , Survival Analysis , Swine
13.
PLoS Pathog ; 5(1): e1000261, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19132089

ABSTRACT

Enterocytozoon bieneusi is the most common microsporidian associated with human disease, particularly in the immunocompromised population. In the setting of HIV infection, it is associated with diarrhea and wasting syndrome. Like all microsporidia, E. bieneusi is an obligate, intracellular parasite, but unlike others, it is in direct contact with the host cell cytoplasm. Studies of E. bieneusi have been greatly limited due to the absence of genomic data and lack of a robust cultivation system. Here, we present the first large-scale genomic dataset for E. bieneusi. Approximately 3.86 Mb of unique sequence was generated by paired end Sanger sequencing, representing about 64% of the estimated 6 Mb genome. A total of 3,804 genes were identified in E. bieneusi, of which 1,702 encode proteins with assigned functions. Of these, 653 are homologs of Encephalitozoon cuniculi proteins. Only one E. bieneusi protein with assigned function had no E. cuniculi homolog. The shared proteins were, in general, evenly distributed among the functional categories, with the exception of a dearth of genes encoding proteins associated with pathways for fatty acid and core carbon metabolism. Short intergenic regions, high gene density, and shortened protein-coding sequences were observed in the E. bieneusi genome, all traits consistent with genomic compaction. Our findings suggest that E. bieneusi is a likely model for extreme genome reduction and host dependence.


Subject(s)
Enterocytozoon/genetics , Genome, Fungal , DNA, Intergenic , Fungal Proteins , Genes, Fungal , Humans , Microsporidiosis , Open Reading Frames , Opportunistic Infections , Sequence Analysis, DNA
14.
J Eukaryot Microbiol ; 54(1): 38-41, 2007.
Article in English | MEDLINE | ID: mdl-17300517

ABSTRACT

Enterocytozoon bieneusi is the most common and clinically significant microsporidium associated with chronic diarrhea and wasting in immunocompromised humans. Albendazole, which is effective against several helminths, protozoa, and microsporidia, is relatively ineffective against infections due to E. bieneusi. A likely explanation for the observed clinical resistance to albendazole was discovered from sequence analysis of the E. bieneusibeta-tubulin from isolates from an infected human and a naturally infected rhesus macaque. The beta-tubulin of E. bieneusi has a substitution at Glu(198), which is one of six amino acids reported to be associated with benzimidazole sensitivity.


Subject(s)
AIDS-Related Opportunistic Infections/parasitology , Enterocytozoon/genetics , Microsporidiosis/parasitology , Simian Acquired Immunodeficiency Syndrome/parasitology , Tubulin/genetics , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/pathology , Albendazole/therapeutic use , Amino Acid Sequence , Animals , Antiprotozoal Agents/therapeutic use , DNA, Ribosomal Spacer/genetics , Enterocytozoon/drug effects , Enterocytozoon/isolation & purification , HIV/physiology , Humans , Macaca mulatta , Microsporidiosis/drug therapy , Microsporidiosis/pathology , Molecular Sequence Data , Sequence Alignment , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Acquired Immunodeficiency Syndrome/pathology , Simian Immunodeficiency Virus/physiology
15.
Infect Immun ; 74(8): 4424-9, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16861628

ABSTRACT

Enterocytozoon bieneusi, a microsporidian, is clinically one of the most significant opportunistic causes of diarrhea and wasting associated with profound human immunodeficiencies. The lack of an animal model for E. bieneusi hinders serious investigations and limits the availability of spores to individuals with severe human immunodeficiency virus/AIDS disease who are infected with E. bieneusi. The development of procedures for purification and concentration of spores from stools of infected humans has led to the production of immune reagents and provided a source of spores to conduct research, including attempts to develop and serially propagate E. bieneusi in rodent models. We have evaluated and successfully infected six different immunodeficient and/or immunosuppressed rodent models and have demonstrated persistent infections lasting at least 18 weeks in SCID mice and in nude rats. To enhance the intensity and duration of infection in these two models, animals were given anti-gamma interferon monoclonal antibody injections at regular intervals. Of the six models evaluated, nude rats and gerbils immunosuppressed with dexamethasone excreted the highest number of spores and for longer time periods. Four different E. bieneusi isolates were equally infectious, and one of them was serially propagated in nude rats six times over a period of 10 months. Typically, rats challenged orally with 10(4) spores yielded 2 x 10(7) to 6.3 x 10(7) spores per single fecal sample when the level of spores was measured 2 weeks later. Rodent models and a nonhuman source of fresh spores will considerably enhance future investigations on this important opportunistic pathogen, including the screening and evaluation of urgently needed chemotherapeutic agents.


Subject(s)
Disease Models, Animal , Enterocytozoon/growth & development , Immunocompromised Host , Microsporidiosis/parasitology , Serial Passage , Adult , Animals , Enterocytozoon/pathogenicity , Gerbillinae , Germ-Free Life , Humans , Immunohistochemistry , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, SCID , Rats , Rats, Nude , Spores, Fungal/growth & development
16.
Infect Immun ; 74(6): 3342-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16714562

ABSTRACT

Bile salts such as sodium taurocholate (NaTC) are routinely used to induce the excystation of Cryptosporidium oocysts. Here we show that NaTC significantly enhanced the invasion of several cultured cell lines by freshly excysted Cryptosporidium parvum and Cryptosporidium hominis sporozoites. A variety of purified bile salts or total bile from bovine also enhanced the invasion of cultured cells by C. parvum. Further studies demonstrated that NaTC increased protein secretion and gliding motility of sporozoites, the key processes for successful invasion. These observations may lead to improved Cryptosporidium infectivity of cultured cells and help future studies on the host-parasite interaction.


Subject(s)
Bile Acids and Salts/pharmacology , Cryptosporidium/pathogenicity , Animals , Cell Line, Tumor , Cells, Cultured , Humans , Taurocholic Acid/pharmacology
17.
Clin Diagn Lab Immunol ; 12(10): 1141-4, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16210474

ABSTRACT

Enterocytozoon bieneusi is clinically the most significant among the microsporidia causing chronic diarrhea, wasting, and cholangitis in individuals with human immunodeficiency virus/AIDS. Microscopy with either calcofluor or modified trichrome stains is the standard diagnostic test for microsporidiosis and does not allow species identification. Detection of E. bieneusi infection based on PCR is limited to a few reference laboratories, and thus it is not the standard diagnostic assay. We have recently reported the development and characterization of a panel of monoclonal antibodies against E. bieneusi, and in this publication we evaluated the specificity and sensitivity of an immunofluorescence assay (IFA), compared with PCR, in simian immunodeficiency virus-infected macaques. The IFA, which correlated with the primary PCR method, with a detection limit of 1.5 x 10(5) spores per gram of feces, will simplify considerably the detection of E. bieneusi spores in clinical and environmental specimens and in laboratory and epidemiological investigations.


Subject(s)
Enterocytozoon/isolation & purification , Feces/microbiology , Fluorescent Antibody Technique/standards , Microsporidiosis/diagnosis , Simian Acquired Immunodeficiency Syndrome/complications , Animals , Antibodies, Monoclonal , Macaca , Sensitivity and Specificity , Simian Acquired Immunodeficiency Syndrome/microbiology , Spores, Fungal/isolation & purification
18.
Infect Immun ; 73(8): 5166-72, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16041034

ABSTRACT

Enterocytozoon bieneusi spores derived from rhesus macaque feces were purified by serial salt-Percoll-sucrose-iodixanol centrifugation, resulting in two bands with different specific densities of 95.6% and 99.5% purity and with a recovery efficiency of 10.8%. An ultrastructural examination revealed typical E. bieneusi spores. Twenty-six stable hybridomas were derived from BALB/c mice immunized with spores and were cloned twice by limiting dilution or growth on semisolid medium. Four monoclonal antibodies (MAbs), reacting exclusively with spores, were further characterized. These MAbs specifically reacted with spores present in stools of humans and macaques, as visualized by immunofluorescence, and with spore walls, as visualized by immunoelectron microscopy. A blocking enzyme-linked immunosorbent assay and Western blotting revealed that the epitope recognized by 8E2 was different from those recognized by 7G2, 7H2, and 12G8, which identified the same 40-kDa protein. These MAbs will be valuable tools for diagnostics, for epidemiological investigations, for host-pathogen interaction studies, and for comparative genomics and proteomics.


Subject(s)
Antibodies, Monoclonal/immunology , Enterocytozoon/immunology , Microsporidiosis/immunology , Animals , Antibodies, Monoclonal/blood , Blotting, Western , Enterocytozoon/ultrastructure , Enzyme-Linked Immunosorbent Assay , Epitope Mapping , Immunohistochemistry , Macaca mulatta , Mice , Microscopy, Electron, Transmission , Microscopy, Immunoelectron , Microsporidiosis/blood , Spores, Protozoan/ultrastructure
19.
Brain Res Bull ; 61(2): 207-17, 2003 Jul 15.
Article in English | MEDLINE | ID: mdl-12832008

ABSTRACT

The effects of lead on the signal transduction pathways that may be involved in the release of gonadotropin-releasing hormone (GnRH) from neurons in the hypothalamus have not been well defined. Using the GT1-7 cell line, an in vitro model for GnRH-secreting neurons, we examined signal transduction pathways directly affected by lead. We found that lead-induced phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1 and ERK2), as well as p90RSK and cAMP response element-binding protein (CREB), but did not induce IkappaB degradation. MEK1/2 inhibitor (PD98059) suppressed lead-induced ERK and p90RSK activation. Neither PKC inhibitors (Go6983, Go6976) nor CaMKII inhibitor (KN-62) had a pronounced effect on lead-induced ERK1 and ERK2 phosphorylation. However, MEK1/2 inhibitor, CaMKII inhibitor, and PKC inhibitor significantly suppressed lead-induced CREB phosphorylation. These results indicate that lead-activated PKC, CaMKII and MEK/ERK/p90RSK pathways simultaneously, all of which contributed to CREB phosphorylation. Our results also indicate that lead-induced p90RSK and CREB activation does not alter expression of early response genes like c-fos. We conclude that lead activates PKC, CaMKII or MEK-ERK-p90RSK pathways in GT1-7 cells, leading to CREB phosphorylation and modulation of gene expression.


Subject(s)
Cell Line, Transformed/drug effects , Organometallic Compounds/pharmacology , Signal Transduction/drug effects , Tetrahydroisoquinolines , Animals , Blotting, Western , Cyclic AMP Response Element-Binding Protein/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Hypothalamic Neoplasms , Isoquinolines/pharmacology , Mice , Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/physiology , Phosphorylation/drug effects , Proto-Oncogene Proteins c-fos/metabolism , Ribosomal Protein S6 Kinases, 90-kDa/metabolism , Serine/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...